Skip to main content
Equibles
AXGN logo

AXGN · Axogen, Inc. · Webcasts, Transcripts & Audio

Track AXGN — free

Use AXGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AXGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$39.92 -2.00 (-4.77%) At close · Oct 1
Russell 2000 member Rebalance outlook locked
Market Cap
$2.28B
Shares
53.76M
Volume · Oct 1 1.6M Avg daily vol (3M) 1.19M

Axogen, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Axogen, Inc. (AXGN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲18.4% $36.96M −$4.32M '22 Q3 22-11-08 ▲14.7% $36.16M −$5.42M '22 Q4 23-01-09 ▲18.2% $36.66M −$7.07M '23 Q1 23-05-09 ▲10.7% $38.16M −$6.66M '23 Q2 23-08-07 ▲11.7% $41.27M −$4.09M '23 Q3 23-11-07 ▲18.7% $42.92M −$3.89M '23 Q4 24-03-05 ▲12.9% $41.38M −$6.63M '24 Q1 24-05-02 ▲25.6% $47.91M −$1.92M '24 Q2 24-08-08 ▲17.9% $48.64M −$1.86M '24 Q3 24-11-07 ▲15.1% $49.40M $450,000 '24 Q4 25-01-10 ▲17.4% $48.56M −$3.83M '25 Q1 25-05-08 ▲18.3% $56.66M $579,000 '25 Q2 25-08-05 ▲23.5% $60.08M $708,000 '25 Q3 25-10-29 ▲21.3% $59.90M −$13.16M '25 Q4 26-02-24 ▲26.6% $61.46M −$19.58M '26 Q1 26-04-28 LATEST ▲23.1% $69.73M −$1.52M '26 Q2 26-07-29
Conference
Investor event
2026-09-10
Axogen, Inc. (AXGN) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-07-29
Axogen, Inc. (AXGN) Q2 2026 Earnings Call Transcript
Confident tone Breast market development Revenue growth and financial performance Extremities, OMF and head and neck
Revenue
$69.73M
▲ 23.1% YoY
Diluted EPS
$-0.03
▼ 400% YoY
Gross margin
72.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-28
Axogen, Inc. (AXGN) Q1 2026 Earnings Call Transcript
Confident tone Revenue growth and financial performance Salesforce expansion and productivity BLA transition and gross margin
Revenue
$61.46M
▲ 26.6% YoY
Diluted EPS
$-0.38
Gross margin
75.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Axogen, Inc. (AXGN) Q4 2025 Earnings Call Transcript
Confident tone Revenue growth and financial performance 2026 guidance and gross margin outlook Breast market development
Revenue
$59.90M*
▲ 21.3% YoY
Gross margin
74.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-29
Axogen, Inc. (AXGN) Q3 2025 Earnings Call Transcript
Confident tone Avance Nerve Graft BLA approval Revenue growth and market expansion High potential accounts strategy
Revenue
$60.08M
▲ 23.5% YoY
Diluted EPS
$0.01
Gross margin
76.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Axogen, Inc. (AXGN) Q2 2025 Earnings Call Transcript
Confident tone Revenue growth and broad market adoption BLA for Avance Nerve Graft Gross margin and product costs
Revenue
$56.66M
▲ 18.3% YoY
Diluted EPS
$0.01
Gross margin
74.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Axogen, Inc. (AXGN) Q1 2025 Earnings Call Transcript
Confident tone BLA approval process for Avance Nerve Graft Guidance and financial outlook Professional education and surgeon training
Revenue
$48.56M
▲ 17.4% YoY
Diluted EPS
$-0.08
Gross margin
71.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-01-10
Axogen, Inc. (AXGN) Q4 2024 Earnings Call Transcript
Positive tone Revenue growth and guidance Breast reconstruction / Resensation Extremities market
Revenue
$49.40M*
▲ 15.1% YoY
Gross margin
76.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Axogen, Inc. (AXGN) Q3 2024 Earnings Call Transcript
Positive tone Revenue and EBITDA growth BLA submission and Avance regulatory New CEO strategic plan
Revenue
$48.64M
▲ 17.9% YoY
Diluted EPS
$-0.04
Gross margin
74.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Axogen, Inc. (AXGN) Q2 2024 Earnings Call Transcript
Confident tone Revenue growth and quarterly results Core accounts and sales force expansion Avance Nerve Graft BLA submission
Revenue
$47.91M
▲ 25.6% YoY
Diluted EPS
$-0.04
Gross margin
73.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Axogen, Inc. (AXGN) Q1 2024 Earnings Call Transcript
Confident tone Quarterly revenue growth and guidance Core accounts and sales force productivity Site of care and ambulatory surgery centers
Revenue
$41.38M
▲ 12.9% YoY
Diluted EPS
$-0.15
Gross margin
78.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-05
Axogen, Inc. (AXGN) Q4 2023 Earnings Call Transcript
Positive tone Revenue Growth and Core Accounts Product Innovation and Launches BLA Submission for Avance Nerve Graft
Revenue
$42.92M*
▲ 18.7% YoY
Gross margin
74.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Axogen, Inc. (AXGN) Q3 2023 Earnings Call Transcript
Revenue
$41.27M
▲ 11.7% YoY
Diluted EPS
$-0.10
Gross margin
76.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Axogen, Inc. (AXGN) Q2 2023 Earnings Call Transcript
Revenue
$38.16M
▲ 10.7% YoY
Diluted EPS
$-0.16
Gross margin
77.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Axogen, Inc. (AXGN) Q1 2023 Earnings Call Transcript
Revenue
$36.66M
▲ 18.2% YoY
Diluted EPS
$-0.17
Gross margin
77.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-01-09
Axogen, Inc. (AXGN) Q4 2022 Earnings Call Transcript
Revenue
$36.16M*
▲ 14.7% YoY
Gross margin
67.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Axogen, Inc. (AXGN) Q3 2022 Earnings Call Transcript
Revenue
$36.96M
▲ 18.4% YoY
Diluted EPS
$-0.10
Gross margin
83.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-18
Axogen, Inc. (AXGN) Q2 2022 Earnings Call Transcript
Revenue
$34.45M
▲ 2.6% YoY
Diluted EPS
$-0.18
Gross margin
81.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
Axogen, Inc. (AXGN) Q1 2022 Earnings Call Transcript
Revenue
$31.01M
▼ 0.1% YoY
Diluted EPS
$-0.27
Gross margin
82.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-22
Axogen, Inc. (AXGN) Q4 2021 Earnings Call Transcript
Revenue
$31.54M*
▼ 2.9% YoY
Gross margin
82.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Axogen, Inc. (AXGN) Q3 2021 Earnings Call Transcript
Revenue
$31.20M
▼ 6.7% YoY
Diluted EPS
$-0.17
Gross margin
83.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Axogen, Inc. (AXGN) Q2 2021 Earnings Call Transcript
Revenue
$33.58M
▲ 51.8% YoY
Diluted EPS
$-0.19
Gross margin
78.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Axogen, Inc. (AXGN) Q1 2021 Earnings Call Transcript
Revenue
$31.04M
▲ 27.9% YoY
Diluted EPS
$-0.16
Gross margin
83.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-22
Axogen, Inc. (AXGN) Q4 2020 Earnings Call Transcript
Revenue
$32.49M
▲ 15.4% YoY
Gross margin
83.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Axogen, Inc. (AXGN) Q3 2020 Earnings Call Transcript
Revenue
$33.43M
▲ 17% YoY
Diluted EPS
$-0.04
Gross margin
83.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-01
Axogen, Inc. (AXGN) Q2 2020 Earnings Call Transcript
Revenue
$22.12M
▼ 17.2% YoY
Diluted EPS
$-0.20
Gross margin
74.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-23
Axogen, Inc. (AXGN) Q1 2020 Earnings Call Transcript
Revenue
$24.26M
▲ 4.2% YoY
Gross margin
80.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-24
Axogen, Inc. (AXGN) Q4 2019 Earnings Call
Revenue
$28.16M
▲ 20.2% YoY
Gross margin
82.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–28 of 28 webcasts
Key facts CIK 805928 CUSIP 05463X106 13F (30d) 6 filings 6 filers Visit website Investor relations